← Back to Search

Behavioral Intervention

App-based remote blood pressure monitoring for Hypertension

Waitlist Available
Led By Adam Lewkowitz, MD, MPHS
Research Sponsored by Women and Infants Hospital of Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Screening 3 weeks
Treatment Varies
Follow Up 3-10 days postpartum
Awards & highlights

Study Summary

This trial showed that a program using text messages, Bluetooth-enabled cuff & AI can provide tailored hypertension support & reduce cost for postpartum blood pressure checks.

Eligible Conditions
  • Pregnancy-Induced Hypertension
  • Hypertension
  • Prophylaxis of Preeclampsia


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-10 days postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-10 days postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood pressure ascertainment
Secondary outcome measures
Adherence to evidence-based practice
Agency for Healthcare Research and Quality Consumer Assessment of Healthcare Providers and Systems survey (AHRQ CAHPS)
Decisional Regret Scale
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: App-based remote blood pressure monitoringExperimental Treatment1 Intervention
Women in this group will receive a Bluetooth-enabled automatic blood pressure cuff that synchs automatically to a smartphone application that incorporates Artificial Intelligence to respond to each recorded measurements with recommended next steps and also document the measurement and response in a secure platform. This affiliated smartphone application will also contain education on hypertension management. Upon receipt of the blood pressure cuff, participants will be instructed to set up the program/app.
Group II: Text-message based remote blood pressure monitoringActive Control1 Intervention
Women in this group will receive current standard of care: remote blood pressure monitoring via text message. Specifically, they will receive automatic blood pressure cuffs, instructions how to obtain their blood pressures and log them into our Electronic Medical Record, and contact information for the nurse practitioner and community health worker managing the program. The NP will respond via text message to each individual measurement with instructions as to next steps.
First Studied
Drug Approval Stage
How many patients have taken this drug
App-based remote blood pressure monitoring

Find a Location

Who is running the clinical trial?

Women and Infants Hospital of Rhode IslandLead Sponsor
110 Previous Clinical Trials
38,696 Total Patients Enrolled
Adam Lewkowitz, MD, MPHSPrincipal InvestigatorWomen and Infants Hospital of Rhode Island

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research accept participants 45 years of age or above?

"This trial seeks participants between 18 and 55 years of age. Alternatively, there are 69 trials for minors and 713 specifically targeting seniors."

Answered by AI

Are there any eligibility requirements for participation in this research?

"This medical trial is recruiting 120 individuals with pre-eclampsia aged between 18 and 55. English or Spanish language proficiency, a history of gestational hypertension, preeclampsia or chronic hypertension, smartphone ownership for remote blood pressure monitoring, and postpartum care at a Women & Infants Hospital (WIH)-affiliated clinic are some of the criteria necessary to be eligible for this study."

Answered by AI

Are there openings for participants in this investigation?

"Data on clinicaltrials.gov reveals that this investigation is actively recruiting patients; it was first published the 7th of November 2022 and updated later on the 15th of same month."

Answered by AI

How many participants are being incorporated into this experiment?

"Affirmative. Data on clinicaltrials.gov states that this study is actively searching for candidates and has been since it was initially posted on November 7th 2022. The trial needs 120 participants from a single site, with the information most recently updated on November 15th of the same year."

Answered by AI
~48 spots leftby May 2025